Workshop on Growth Hormone Therapy
Growth hormone deficiency and growth failure may occur during infancy or later in childhood and without treatment most children with growth hormone deficiency will not reach a height of 5 feet.
Some growth problems are genetic, while others may be caused by hormonal disorders or even poor absorption of food. These children are most often socially victimised and suffer in silence in every phase of life.
Sandoz Division of Novartis (Bangladesh) Limited organised a workshop for child specialists on Growth Hormone Therapy at a hotel in the city recently. Around 150 national specialists graced the event. National Prof M R Khan, Prof Zafer A Latif, and international speakers Prof Dr Rolf Peter Willing, specialist on adolescent endocrinology and Dr Dieter Braun, Global Head of Marketing and Sales Biopharmaceuticals, Sandoz International, discussed the latest on the endocrine basis of growth and development at the first training workshop on "Growth Hormone Therapy and Omnitrope".
Prof Zafar A Latif focused on the need of patients, where he mentioned that the problem of short stature is not only limited within the low income group but in his professional life he has encountered many patients from affluent family. He expressed gratitude to Sandoz for bringing short stature to attention and staging such platform for the Pediatricians and endocrinologists for the first time in Bangladesh.